Nawsherwan Mohammad/Instagram
Jun 23, 2026, 10:22
Nawsherwan Mohammad: Thrombocytopenia in Pregnancy – Not Always Benign
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn:
“Thrombocytopenia in Pregnancy: Not Always Benign
Thrombocytopenia affects approximately 7–10% of pregnancies and ranges from benign conditions to life-threatening disorders.
Common causes include:
- Gestational thrombocytopenia (75%) – mild, usually >70 ×10⁹/L, asymptomatic, and resolves after delivery.
- Immune thrombocytopenia (ITP) – may occur at any stage of pregnancy and can affect both mother and fetus.
- Preeclampsia/HELLP syndrome – associated with hypertension, hemolysis, and elevated liver enzymes; requires urgent management.
- Less common but critical causes: Thrombotic thrombocytopenic purpura (TTP), disseminated intravascular coagulation (DIC), infections, and inherited thrombocytopenias.
Key message:
A low platelet count in pregnancy should never be dismissed without clinical context.
Platelet count severity, gestational age, blood pressure, liver enzymes, hemolysis markers, and peripheral blood smear findings are essential for accurate diagnosis.
Early recognition can be lifesaving for both mother and baby.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments